ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,917.11
0.00%
US Tech 100
20,029.60
-0.48%
다우존스 지수
43,408.47
0.32%
Bitcoin
97,545.04
3.38%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU

  6. Genfit (GNFT) 시세

Genfit

Genfit (GNFT)

Genfit SA
4.03
0.005
( 0.12% )
업데이트: 18:47:35
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
4.03
매수가
4.025
매도가
4.045
거래량
67,863
4.00 일간 변동폭 4.08
2.90 52주 범위 5.86
market_cap
200.835M
전일 종가
4.025
개장가
4.025
최근 거래 시간
1
@
4.03
마지막 거래 시간
18:46:46
재정 규모
-
VWAP
-
평균 볼륨(3m)
329,918
발행 주식
49,834,983
배당수익률
-
주가수익률
-6.99
주당순이익(EPS)
-0.58
매출
38.68M
순이익
-28.89M

Genfit 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.genfit.com
본부
Loos, Nord, Fra
설립됨
-
Genfit is listed in the Pharmaceutical Preparations sector of the 유로넥스트 (Euronext) with ticker GNFT. The last closing price for Genfit was 4.03 €. Over the last year, Genfit shares have traded in a share price range of 2.90 € to 5.86 €.

Genfit currently has 49,834,983 shares in issue. The market capitalisation of Genfit is 200.59 € million. Genfit has a price to earnings ratio (PE ratio) of -6.99.

GNFT 최신 뉴스

추가 뉴스

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024 Programme PBC (sous licence Ipsen) : Ipsen présentera de nouvelles...

14 11월 2024
UK Regulatory

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch...

14 11월 2024
UK Regulatory

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from...

14 11월 2024
GlobeNewswire Inc.

GENFIT : Information financière du troisième trimestre 2024

GENFIT : Information financière du troisième trimestre 2024 Trésorerie et équivalents de trésorerie s’élevant à 96,0 millions d’euros au 30 septembre 202459,7 millions d’euros de revenus des neuf...

08 11월 2024
UK Regulatory

GENFIT Reports Third Quarter 2024 Financial Information

GENFIT Reports Third Quarter 2024 Financial Information Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30...

08 11월 2024
UK Regulatory

GENFIT Reports Third Quarter 2024 Financial Information

Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30, 2024, including the €48.7 million milestone invoiced in...

08 11월 2024
GlobeNewswire Inc.

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval Lille (France), Cambridge...

23 9월 2024
UK Regulatory

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA américaine

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA...

23 9월 2024
UK Regulatory

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 23, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to...

23 9월 2024
GlobeNewswire Inc.

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société Trésorerie et équivalents de trésorerie s’élevant à 61,6 millions d’euros au 30 juin 2024 n’incluant...

20 9월 2024
UK Regulatory
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.86-17.58691206544.894.95543890694.21865211DE
4-1.1-21.44249512675.135.6343089324.84695135DE
120.225.774278215223.815.863.6253299184.88489033DE
260.215.497382198953.825.863.473368284.60069643DE
520.8827.93650793653.155.862.92661904.1943634DE
1560.85226.8093140343.1785.862.7462144903.94029017DE
260-9.87-71.007194244613.920.962.7463087035.60555573DE

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ALMASMastrad
0.0136 €
(58.14%)
977k
BIDSGascogne DS
0.0028 €
(55.56%)
40.05k
SOISOITEC
75.55 €
(18.98%)
197.95k
ATODSAtos SE
0.0047 €
(14.63%)
12.34M
HYLHyloris Pharmaceuticals SA
5.88 €
(13.51%)
38.34k
EBUSEbusco Holding NV
0.9272 €
(-24.37%)
1.5M
VACBSPierre & Vacances
0.048 €
(-14.29%)
427
EMGDSEuromedis DS
0.0088 €
(-12.00%)
2.65k
ALVETTheraVet SA
0.0804 €
(-10.67%)
28.93k
SEFERSergeferrari Group
5.36 €
(-10.52%)
3.26k
ATODSAtos SE
0.0047 €
(14.63%)
12.34M
ALVERVergnet
0.005 €
(4.17%)
7.74M
BCPBanco Comercial Portugues SA
0.4359 €
(-0.89%)
7.07M
ALTDTonner Drones
0.0102 €
(10.87%)
6.92M
ATOAtos SE
0.1769 €
(-8.10%)
3.13M

토론

전체 피드 보기
aniyahsbednar aniyahsbednar 6 분 전
https://claritybloomcbdgummies.linkpc.net/
aniyahsbednar aniyahsbednar 7 분 전
https://www.facebook.com/vitaslimketogummies/
Patient Ninja Patient Ninja 7 분 전
Tommy got close to half million in bitcoin as it gets close to 100k. He may have more bitcoin now. Maybe a million worth.

Sell some bitcoin Tommy. Pay off the corrupt MM and let's get going buddy.

After that we can show a paid poster and basher where the sun don't shi
CCTL
Golden Cross Golden Cross 8 분 전
$ILLR ✨ ILLR Update: Former Head of Product at TikTok Sean Kim joins Triller Group
https://www.youtube.com/watch?v=2Nq9YJiZt8U

[yt]2Nq9YJiZt8U[/yt]
ILLR
XenaLives XenaLives 9 분 전
LOL!!! DFCO is a typical BONAR pump and dump.

No fundamentals at all here.....
DFCO
Methinks Methinks 9 분 전
https://www.widepoint.com/widepoint-certifies-new-proprietary-mobileanchor-digital-credential-for-mobile-devices/
Found this, and thanks, Bull_Dolphin. I look forward to hearing more about the DAAS partnership.
WYY
aniyahsbednar aniyahsbednar 9 분 전
Official Website... https://cutt.ly/BeKWwPJc

Vital Grow XL Gummies are formulated to enhance male performance, vitality, and overall wellness. Designed with convenience and natural ingredients in mind, these gummies aim to provide benefits like improved stamina, testosterone support,
Golden Cross Golden Cross 10 분 전
$ILLR ✨ ILLR Update: Former Head of Product at TikTok Sean Kim joins Triller Group
https://www.youtube.com/watch?v=2Nq9YJiZt8U

[yt]2Nq9YJiZt8U[/yt]
ILLR
Methinks Methinks 13 분 전
https://www.widepoint.com/widepoint-certifies-new-proprietary-mobileanchor-digital-credential-for-mobile-devices/

"Direct Integration: WidePoint’s MobileAnchor™ generates a digital credential directly on the device, can leverage device-specific security features, such as hardware-base
diggitydoodle diggitydoodle 18 분 전
A lot of giving opinions, predicting, hoping & wishing what this tickers great CEO will do. Based on reading into things without those things specifically being written in any of the reports coming out.
This great CEO can't put out timely fins. And, doesn't give updates, even of the most gen
RNVA
TheFinalCD TheFinalCD 18 분 전
RMSG 7
CRAZY SWINGS FROM
55- TO 2.65 TO 10.70

RMSG
https://finance.yahoo.com/news/real-messenger-nova-vision-acquisition-210800321.html
RMSG
aniyahsbednar aniyahsbednar 20 분 전
Official Website... https://cutt.ly/keKQ376J

MaxBoost Plus is a premium male enhancement supplement designed to help men improve stamina, vitality, and overall confidence. Using a powerful blend of natural ingredients, it supports testosterone levels, blood flow, and energy, empowerin
TrendTrade2016 TrendTrade2016 20 분 전
BDPT FIRST TRIP REVERSE SPLIT TO HIT...GET READY CLOWNS...THIS IS THE BEGINNING TO THEBIGGEST OTC RS CAMPAIGN IN A DECADE
BDPTD
Truth_is_a_tool Truth_is_a_tool 24 분 전
I feel a disturbance in the force too lol and I’m going to go ahead and agree. I feel we will have a PR in less than 3 hours.
KBLB
Truth_is_a_tool Truth_is_a_tool 26 분 전
Hi M4N , my concern was that it was in the latest prospectus that just came out but you and Mojo are probably right that it’s just a copy and paste. Either way im not really concerned as it doesn’t change my view that this company will have a breakout soon enough , whether it’s this year or the next
KBLB
Bull_Dolphin Bull_Dolphin 28 분 전
Yay!!!!

https://www.breitbart.com/entertainment/2024/11/20/ellen-degeneres-leaves-united-states-flees-to-england-over-trump-election/
Minddoc7 Minddoc7 28 분 전
Coinbase CEO Brian Armstrong Perfect For Crypto Czar Role - Charles Hoskinson

"Cardano founder Charles Hoskinson has thrown his weight behind Coinbase CEO Brian Armstrong as the best choice for a potential “crypto czar” position in the Trump administration.

The informal
COIN
Seminole Red Seminole Red 30 분 전
good job
cowtown jay cowtown jay 32 분 전
How much longer can it be before we start to see detailed stock quotes on this site (advfn) again? So many pieces of the puzzle are starting to be displayed, they have got to be near the point where they are snapped together. We've got to be generating revenue by now.

https://www.ad
aniyahsbednar aniyahsbednar 34 분 전
Official Website... https://cutt.ly/qeKQMuOM

VitalRize Male Enhancement is a cutting-edge supplement designed to help men regain their stamina, boost testosterone levels, and improve overall confidence. With a blend of natural and clinically tested ingredients, VitalRize offers a holi

최근 히스토리

EU
GNFT
Genfit
BOV
SUZB3
SUZANO PAPEL ON
USOTC
MMTMF
Monument Mining (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유